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Abstract
Background—Previous studies of the reproducibility of blood pressure (BP) dipping have
yielded inconsistent results. Few have examined factors that may influence dayto-day differences
in dipping.
Methods and Results—Ambulatory BP monitoring was performed on three occasions,
approximately one week apart, in 115 untreated adult subjects with elevated clinic BPs. The mean
±SD BP dip was 18±7/15±5 mmHg (sleep/awake BP ratio = 0.87±0.05/0.82±0.06), with a median
(interquartile range) day-to-day variation of 5.2 (3.1–8.1)/4.3(2.8–5.6) mmHg. There was no
decrease in variability with successive measurements. The reproducibility coefficient (5.6 [95% CI
5.1, 6.1] mmHg) was greater and the intraclass correlation coefficient (0.53 [95% CI 0.42, 0.63])
was smaller for the systolic dip than for 24-hour or awake systolic BPs, suggesting greater day-
today variability in dipping. Variability in systolic dipping was greater in subjects with higher
awake BP, but was not related to age, gender, race, or body mass index. Within individuals, day-
to-day variations in dipping were related to variations in the fragmentation index (p < 0.001), a
measure of sleep quality.
Conclusions—Although mean 24-hour and awake BPs were relatively stable over repeated
monitoring days, our study confirms substantial variability in BP dipping. Day-to-day differences
in dipping are related to sleep quality.
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Measurement of blood pressure (BP) throughout the day using ambulatory BP monitoring
(ABPM) permits quantification of the “average” BP over 24 hours, as well as an assessment
of the diurnal pattern of BP variation. Multiple studies have demonstrated that average
ambulatory BP is more predictive of end-organ damage and of adverse cardiovascular
events than is clinic BP. (1–11) Similarly, the diurnal pattern of BP variation may be of
prognostic significance, with non-dippers – i.e., individuals with a small or no fall in BP
during sleep – at increased risk of adverse cardiovascular outcomes. (1,2,4,5,8,10,12–19)
One factor that has limited enthusiasm for incorporating measurement of the BP dip into the
clinical evaluation and management of patients is concern over the reproducibility of this
measurement. Previous studies evaluating the day-to-day consistency of the diurnal BP
profile have yielded differing results that have been influenced by factors such as the age,
co-existing medical conditions, and treatment of the subjects, as well as the time interval
between successive measurements. (17,20–27) Some have focused on the classification of
patients as dippers or non-dippers based on defined partition values, an approach in which
individual subjects may have discordant results from one monitoring session to the next
despite quantitatively small differences in the BP fall during sleep. Few have examined the
impact of demographic characteristics or of day-to-day variation in sleep quality or daytime
activity levels on the reproducibility of the BP dip.
In this study, we quantitatively examined the reproducibility of the BP dip and other
measures of ambulatory BP in a cohort of generally healthy subjects with elevated clinic
BPs who underwent ABPM on three occasions. We also assessed the influences of
demographic features, awake BP levels, sleep duration and quality, and awake physical
activity levels on day-to-day variations in BP dipping.
METHODS
Subjects
Participants included generally healthy men and women between the ages of 40 and 60 years
who had never been treated with anti-hypertensive medications and who had screening
systolic BPs of 130–159 mmHg and/or diastolic BPs of 85–99 mmHg. Individuals at high
risk of sleep apnea, based on clinical history or on screening using the Duke Structured
Interview for Sleep Disorders (28) and Berlin Sleep Apnea Index (29), were excluded. Other
exclusion criteria have been described elsewhere in detail (30), and included diabetes, atrial
fibrillation, chronic kidney disease, use of oral contraceptives or hormone replacement
therapy, or incomplete data on any one of the three ABPM sessions. Participants were
recruited by paid advertisements. The study was approved by the Institutional Review Board
at Duke University Medical Center, Durham, NC, and written informed consent was
obtained from all participants prior to their participation.
Screening BP
Screening BPs were acquired on three separate visits to the research laboratory, each
approximately one week apart. At each visit, with the subject seated in a quiet, temperature
controlled room, four seated BP measurements were acquired by a trained technician using a
mercury sphygmomanometer. The BP for each visit was calculated as the mean of the last
three readings, and eligibility for the study was based upon the average of the BP values
from each of the three visits.
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Data on age, gender, ethnicity, height, and weight were acquired on screening visits. Body
mass index (BMI) was calculated as weight (kg)/height (m)2.
ABPM
ABPM was performed using an OSCAR II monitor (Suntech Medical, Inc., Raleigh, NC),
an oscillometric device that has been validated for accuracy.(31,32) Twenty-four hour
records were acquired on three typical work days, separated by approximately one week.
The monitor was programmed to make BP measurements every 20 minutes during the day
and every 30 minutes at night. A minimum of 6 valid measurements were required during
the sleep period, and 20 valid measurements were required during the waking period.
Assessment of sleep duration and quality and of daytime activity levels
Waking and sleep periods were defined by self-report diaries and confirmed by actigraphy.
The actigraphy monitor (Mini-Mitter, Inc., Sunriver, OR) is worn around the wrist and
contains a calibrated accelerometer that samples movement and activity at a rate of 32/sec.
The actigraphy-based fragmentation index, a measure of the restlessness of sleep, was
defined as the sum of 2 percentages: the percentage of the sleep period spent moving, and
the percentage of the number of immobile phases that were ≤ 1 minute long. Sleep
efficiency was defined as the percent of time asleep during the time in bed. Previous studies
have demonstrated that actigraphic measures reflect sleep quality as assessed by
polysomnography. (33,34) Daytime activity was expressed as the average activity counts/
minute during the waking period.
Data analysis
All analyses were performed using SAS statistical software, version 9.3 (SAS, Cary, NC).
Waking and sleep systolic BPs for each individual were computed as the averaged awake
and sleep BPs for each of the three monitoring sessions. The systolic BP dip for each session
was derived by subtracting mean sleep systolic BP from mean awake systolic BP, and the
systolic sleep/awake BP ratio was calculated as mean systolic sleep BP/mean systolic awake
BP. The day-to-day variability for each measure of systolic BP and systolic BP dipping was
quantified for each subject as the average absolute variation (the mean absolute difference in
values between sessions 1 and 2, sessions 2 and 3, and sessions 3 and 1). Analogous
calculations were made for diastolic BPs. For descriptive purposes, a dipper was defined by
systolic and diastolic sleep/awake BP ratios ≤ 0.90, while subjects with either a systolic or
diastolic sleep/awake BP ratio of > 0.90 were classified as nondippers.
The day-to-day variability in each measure of sleep duration and quality and of daytime
activity levels was quantified as the average absolute variation over the 3 sessions.
Descriptive statistics were summarized as mean±SD for continuous demographic variables
and for measures of BP, sleep, and activity; as median (interquartile range) for measures of
day-to-day variability; and as number (%) of subjects for categorical variables.
Differences in mean BP measurements (screening, awake, sleep, dip, and sleep/awake ratio)
on sessions 1, 2, and 3 were examined using repeated measures analysis of variance.
The reproducibility of the systolic BP dip between sessions 1 and 2, 2 and 3, and 1 and 3
were illustrated by Bland Altman plots, and plots were also constructed to illustrate the
reproducibility of systolic BP dip in comparison to other measure of systolic BP between
sessions 1 and 2. Utilizing the data from all 3 sessions, the reproducibility coefficient of
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each measure of BP was defined as the within-subject standard deviation (Sw) derived from
a one-way analysis of variance. The intraclass correlation coefficient, an index describing
the proportion of the total variance in BP measurements that is due to “true” differences
between subjects, was calculated from the between-subject and error variances of the one-
way analysis of variance (R = σ2subjects /(σ2subjects + σ2error) = (MSsubjects – MSerror)/
(MSsubjects + 2 MSerror), where MS = mean square). The levels of agreement between
sessions 1 and 2, 2 and 3, and 1 and 3 in classification of subjects as dippers or nondippers
were quantified using the kappa statistic.
The relationships of awake BP and continuous demographic variables (age and BMI) to the
average absolute variation in the BP dip were examined with Spearman’s correlations.
Gender and race (classified as white or non-white) differences in the variation in BP dipping
were assessed by the Wilcoxon rank sum test.
Mixed models were utilized to examine the impact of within-subject differences in sleep
duration, sleep quality (fragmentation index and sleep efficiency), and daytime physical
activity (quantified as the average activity counts/minute) on day-to-day differences in BP
dipping. The mixed models were constructed to recognize that ambulatory BP data have two
components: one due to the sampling of subjects and the other due to the sampling of
repeated measurements within subjects. In order to estimate the impact of intra-individual
day-to-day differences (rather than inter-individual differences) in sleep duration and quality
and in daytime activity, average values across the 3 sessions for sleep duration, sleep quality
measures, and activity counts/minute for each subject were included in the models.
RESULTS
The demographic characteristics of the 115 study participants are summarized in Table 1.
The average age was 46±9 years; 43% of the subjects were female. There were 63 (55%)
whites, 42 (37%) African Americans, and 10 (9%) subjects of other ethnicities. The mean
awake BP was 136±11/84±8 mmHg, with a dip of 18±7/15±5 mmHg. The systolic and
diastolic sleep/awake BP ratios were 0.87±0.05 and 0.82±0.06, respectively. The
percentages of subjects qualifying as dippers were 65%, 66%, and 70%, respectively, on the
three sessions (data not shown). Measures of sleep duration and quality and of daytime
activity levels are shown in Table 2; the typical sleep period duration was 7.6±1.0 hours per
night.
The reproducibility of the systolic BP dip between sessions 1 and 2, 2 and 3, and 1 and 3 is
illustrated by Bland Altman plots in Figure 1. There was no decrease in the within-
individual day-to-day variability of the BP dip with successive measurements. The greater
variability in screening BP, sleep BP, and BP dip than in awake BP is shown in Figure 2. A
shift on successive measurements was noted only for screening BPs, which averaged 142±9
mmHg on visit 1, 140±8 mmHg on visit 2, and 138±8 mmHg on visit 3 (p<0.0001 for
difference between sessions); mean awake and sleep ambulatory BPs and the BP dip
remained stable across monitoring sessions. Similar findings were noted when measures of
diastolic BP were examined (data not shown).
The median (interquartile range) absolute day-to-day variation in systolic/diastolic BP dip
was 5.2 (3.1–8.1)/4.3(2.8–5.6). The absolute day-to-day variation, reproducibility coefficient
(within-subject standard deviation), and intraclass correlation coefficient (proportion of the
total variance in BP due to “true” differences between subjects) for each measure of systolic
BP are shown in Table 3. The lowest intraclass correlations were for the BP dip and the
sleep/awake BP ratio, reflecting the considerable day-today variability in these
measurements and the relatively constricted range of values. Similarly, the diastolic BP dip
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and sleep/awake BP ratio had the lowest intraclass correlations (0.48, 95% CI 0.37, 0.58;
and 0.54, 95% CI 0.43, 0.63, respectively) amongst measures of diastolic BP (data not
shown). Of note, average awake BP was more reproducible than either sleep BP or
screening BP.
There was agreement between sessions 1 and 2 in categorizing individuals as dippers or
nondippers in 74% of subjects, with a kappa coefficient of 0.41; agreement between sessions
2 and 3 in 76% of subjects, with a kappa of 0.43; and agreement between sessions 1 and 3 in
70% of subjects, with a kappa of 0.31.
The average absolute variation of systolic BP dipping was significantly correlated with
awake systolic BP (r=0.27, p=0.003). Subjects with a greater BMI tended to exhibit more
day-to-day variability in systolic dipping (r = 0.16, p = 0.077), but this tendency did not
achieve statistical significance. There was no apparent relationship of age to the magnitude
of systolic dipping variability (r=-0.06, p=0.496). There were no differences in systolic BP
dipping variability by gender (p=0.446) or race (p=0.954).
The relationships of sleep duration and quality and awake physical activity to intra-
individual day-to-day differences in systolic BP dip were examined in the mixed models
shown in Table 4. Day-to-day measures of sleep fragmentation index were predictive of the
systolic BP dip (p = 0.001). Sleep efficiency also tended to predict the day-to-day systolic
BP dip, but this relationship did not achieve statistical significance (p=0.096). In contrast,
neither sleep period duration nor awake physical activity was related to day-to-day
differences in systolic BP dipping. Day-to-day measures of fragmentation index were also
related to the systolic sleep/awake BP ratio (p = 0.003) and diastolic BP dip and sleep/awake
BP ratio (p = 0.017 and p = 0.016, respectively; data not shown).
To illustrate the influence of within-subject day-to-day variability in sleep quality on
systolic BP dipping variability, we compared subjects with high variability in fragmentation
index (in the highest quartile for absolute day-to-day variation in fragmentation index) to
those with low fragmentation index variability (in the lowest quartile for absolute variation).
The absolute day-to-day variations in both systolic BP dip (6.7 [5.0–9.5] vs 4.1 [3.0–7.0]
mmHg, p = 0.021) and sleep/awake BP ratio (0.051 [0.023–0.057] vs 0.031 [0.023–0.047], p
= 0.031) were significantly greater in subjects with greater variability in sleep quality.
DISCUSSION
Our study confirms previous research suggesting that there is substantial day-today
variability in BP dipping. In our cohort of untreated middle-aged men and women with high
normal or mildly elevated BPs, the systolic BP dip was less reproducible than average 24-
hour or awake ambulatory systolic BP, and varied by a median of 5.2 (interquartile range
3.1–8.1) mmHg from one measurement to the next. The magnitude of the variability in
systolic BP dipping was greater in subjects with higher levels of awake BP. In individual
subjects, the day-to-day differences in systolic BP dip were related to sleep quality, but not
to sleep period duration or to the level of physical activity while awake.
Many of the previous studies evaluating the reproducibility of the diurnal BP profile have
examined the reliability of ABPM in classifying individuals as dippers or non-dippers based
on a specified partition value (generally a 10% or greater fall in BP during sleep hours).
Cuspidi, et al (35), for example, studied short term reproducibility of the circadian BP
profile in 619 never-treated hypertensive patients by performing 24-hour ABPM twice in
four weeks. A total of 407 of the 619 subjects were categorized as “dippers” during the first
monitored session, but 24% changed classification on repeat monitoring. The variability in
BP dipping was not predicted by age or gender. Omboni, et al (36) reported that
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approximately 40% of the hypertensive patients enrolled in SAMPLE (Studies on
Ambulatory Monitoring of Pressure and Lisinopril Evaluation) changed dipping pattern
when ABPM was repeated after one year. In a report from the Spanish ambulatory blood
pressure monitoring registry, Hernandez del Rey, et al (20) examined the reproducibility of
the circadian BP profile between the first and second 24-hour periods in hypertensive
patients who underwent monitoring for 48 hours. Although the percentages of patients
categorized as dippers were similar in the two periods (47% on the first day, 50% on the
second day), 24% changed classification.
When the reproducibility of dipping is based on dichotomizing subjects as dippers or non-
dippers, even small changes from one monitoring session to the next may result in a change
in classification and lead to the conclusion that reproducibility is poor. Few studies have
examined the reproducibility of the diurnal BP profile expressing dipping as a continuous
variable. McGowan, et al (37) analyzed nocturnal BP dipping in a retrospective examination
of a sample of 512 never-treated patients with two ABPM assessments 29±19 months apart.
Consistent with prior studies, 24% of patients changed systolic BP dipping status from one
session to the next. The mean nocturnal systolic BP dip was 14±5%. The median absolute
difference in systolic BP dip between sessions was 3.8%, with an intraclass correlation of
0.60.
Our study extends the findings of McGowan, et al (37) by examining the short term
reproducibility of dipping over three sessions in a more controlled setting, and by examining
demographic and behavioral characteristics that may impact reproducibility. The magnitude
of the variation in BP dip observed in our subjects was similar to that described by
McGowan, et al (37) and did not diminish with the third monitoring session. The variability
in BP dipping was not significantly related to age, gender, race, or body mass index.
However, day-to-day differences in sleep quality, as measured by the actigraphy-based
fragmentation index, had a major influence on the systolic BP dip.
We are not aware of previous studies that have rigorously examined the influences of day-
to-day differences in sleep quality on intra-individual variability in BP dipping. Manning, et
al (24) noted that self reported poor sleep quality was associated with an attenuated systolic
BP dip, but whether day-to-day differences in sleep quality contributed to the lack of
reproducibility was not specifically analyzed. A previous analysis of our subject cohort
established sleep quality as an independent predictor of between-individual differences in
BP dipping. (30) When the BP dip was calculated as the difference between awake and sleep
BPs averaged over the three sessions, blunted systolic BP dipping was associated with poor
sleep quality as well as a greater body mass index and a smaller fall in sleep period
sympathetic nervous system activity. These three factors contributed to an attenuated fall in
sleep systolic BP observed in African Americans. Similarly, in a group of 186 participants in
the sleep SCORE study, poor sleep quality as indicated by a greater sleep fragmentation
index was associated with higher sleep/awake systolic blood pressure ratios (i.e., with a
smaller systolic BP dip) in both normotensive and hypertensive individuals. (38)
Although the focus of this report is on BP dipping, our study provides insights into the
reproducibility of other measure of BP. Mean 24-hour, awake, and sleep BPs for the group
were consistent across the 3 monitoring sessions. This finding is in contrast to some
previous studies that have described an “ABPM effect” with higher BP on the initial session,
presumably due to the novelty of wearing a device for the first time. (39,40) The average
research clinic BP decreased over successive visits, however. Even though group averages
for sleep BP and BP dip were consistent over the 3 monitoring sessions, day-to-day
variability was greater for these measures than average awake BP, as has been described by
other investigators. (17,21,27) This may reflect, to some degree, the smaller number of BP’s
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sampled during sleep. Despite careful attention to measurement technique, the day-to-day
variability in research clinic BP was greater than for awake ambulatory BP.
Strengths of our study include the focus on generally healthy, middle-aged subjects with
clinic BPs that averaged about 140/90 mm Hg – individuals in whom ABPM data may prove
valuable in diagnosing hypertension and guiding therapy. Our estimates of variability may
not apply, however, to older individuals or to patients with higher BPs or treated
hypertension. In addition, our study was conducted in subjects who volunteered for an
ABPM monitoring research protocol and were tolerant of repeated monitoring sessions; BP
measurements may not be as reliable in less selected patients who undergo monitoring as
part of a clinical evaluation. Lastly, the cross-sectional design of our study limits inferences
regarding cause-and-effect relationships between clinical characteristics, behaviors, and BP
variability.
ABPM is a valuable tool for estimating an individual’s “true” BP and is more accurate than
clinic BP in defining cardiovascular risk. Moreover, a recent analysis suggests that ABPM
may be cost-effective in identifying patients who would benefit from antihypertensive
therapy. (41) These observations led to the recent recommendation by the United Kingdom’s
National Institute for Health and Clinical Excellence (NICE) that ABPM should be routinely
employed in the evaluation of untreated patients with elevated clinic BP. (42) Additional
research is needed to clarify the physiologic basis and prognostic significance of BP
dipping, and to further characterize the factors – including poor sleep quality -- that may
contribute to the day-to-day variability in this measurement. Our findings support the NICE
recommendation to use average awake BP in diagnosing hypertension in a patient who has a
single assessment of ambulatory BP. In view of the considerable variability in the diurnal
pattern of BP, repeated ABPM sessions may be required to confidently estimate an
individual patient’s BP dip.
Acknowledgments
We thank Julie Bower, Amy Franklin, and Angela Kirby for their work in supporting the conduct of this study.
This study was supported by Grant HL072390 from the National Heart, Lung, and Blood Institute, National
Institutes of Health, Bethesda, MD, and grant M01-RR-30 from the General Clinical Research Center program,
National Center for Research Resources, National Institutes of Health.
References
1. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood
pressure. An independent predictor of prognosis in essential hypertension. Hypertension. 1994 Dec;
24(6):793–801. [PubMed: 7995639]
2. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH, et al.
Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N
Engl J Med. 2003 Jun 12; 348(24):2407–2415. [PubMed: 12802026]
3. Bjorklund K, Lind L, Zethelius B, Berglund L, Lithell H. Prognostic significance of 24-h
ambulatory blood pressure characteristics for cardiovascular morbidity in a population of elderly
men. J Hypertens. 2004 Sep; 22(9):1691–1697. [PubMed: 15311096]
4. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C. Ambulatory blood pressure and
mortality: a population-based study. Hypertension. 2005 Apr; 45(4):499–504. [PubMed: 15753229]
5. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, et al. Superiority of ambulatory over
clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension.
2005 Jul; 46(1):156–161. [PubMed: 15939805]
6. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA. 1983
May 27; 249(20):2792–2798. [PubMed: 6842787]
Hinderliter et al. Page 7













7. Ohkubo T, Imai Y, Tsuji I, Nagai K, Watanabe N, Minami N, et al. Relation between nocturnal
decline in blood pressure and mortality The Ohasama Study. Am J Hypertens. 1997 Nov; 10(11):
1201–1207. [PubMed: 9397237]
8. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K. Stroke prognosis and
abnormal nocturnal blood pressure falls in older hypertensives. Hypertension. 2001 Oct; 38(4):852–
857. [PubMed: 11641298]
9. Dawes MG, Coats AJ, Juszczak E. Daytime ambulatory systolic blood pressure is more effective at
predicting mortality than clinic blood pressure. Blood Press Monit. 2006 Jun; 11(3):111–118.
[PubMed: 16702819]
10. Mesquita-Bastos J, Bertoquini S, Polonia J. Cardiovascular prognostic value of ambulatory blood
pressure monitoring in a Portuguese hypertensive population followed up for 8.2 years. Blood
Press Monit. 2010 Oct; 15(5):240–246. [PubMed: 20616705]
11. Franklin SS, Thijs L, Hansen TW, Li Y, Boggia J, Kikuya M, et al. Significance of white-coat
hypertension in older persons with isolated systolic hypertension: a metaanalysis using the
International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular
Outcomes population. Hypertension. 2012 Mar; 59(3):564–571. [PubMed: 22252396]
12. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet. 1988 Aug 13.2(8607):397.
[PubMed: 2899801]
13. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic
significance of the nocturnal decline in blood pressure in individuals with and without high 24-h
blood pressure: the Ohasama study. J Hypertens. 2002 Nov; 20(11):2183–2189. [PubMed:
12409956]
14. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with
selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension.
2006 May; 47(5):846–853. [PubMed: 16567588]
15. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, et al. Predicting
cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic
hypertension Systolic Hypertension in Europe Trial Investigators. JAMA. 1999 Aug 11; 282(6):
539–546. [PubMed: 10450715]
16. Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. Predictors of all-cause
mortality in clinical ambulatory monitoring: unique aspects of blood pressure during sleep.
Hypertension. 2007 Jun; 49(6):1235–1241. [PubMed: 17389258]
17. Schwartz GL, Turner ST, Moore JH, Sing CF. Effect of time of day on intraindividual variability
in ambulatory blood pressure. Am J Hypertens. 2000 Nov; 13(11):1203–1209. [PubMed:
11078181]
18. Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML, et al. Daytime and
nighttime blood pressure as predictors of death and cause-specific cardiovascular events in
hypertension. Hypertension. 2008 Jan; 51(1):55–61. [PubMed: 18039980]
19. Ingelsson E, Bjorklund-Bodegard K, Lind L, Arnlov J, Sundstrom J. Diurnal blood pressure pattern
and risk of congestive heart failure. JAMA. 2006 Jun 28; 295(24):2859–2866. [PubMed:
16804152]
20. Hernandez-del Rey R, Martin-Baranera M, Sobrino J, Gorostidi M, Vinyoles E, Sierra C, et al.
Reproducibility of the circadian blood pressure pattern in 24-h versus 48-h recordings: the Spanish
Ambulatory Blood Pressure Monitoring Registry. J Hypertens. 2007 Dec; 25(12):2406–2412.
[PubMed: 17984661]
21. Palatini P, Mormino P, Canali C, Santonastaso M, De Venuto G, Zanata G, et al. Factors affecting
ambulatory blood pressure reproducibility. Results of the HARVEST Trial Hypertension and
Ambulatory Recording Venetia Study. Hypertension. 1994 Feb; 23(2):211–216. [PubMed:
8307631]
22. James MA, Fotherby MD, Potter JF. Reproducibility of the circadian systolic blood pressure
variation in the elderly. J Hypertens. 1995 Oct; 13(10):1097–1103. [PubMed: 8586801]
23. Mochizuki Y, Okutani M, Donfeng Y, Iwasaki H, Takusagawa M, Kohno I, et al. Limited
reproducibility of circadian variation in blood pressure dippers and nondippers. Am J Hypertens.
1998 Apr; 11(4 Pt 1):403–409. [PubMed: 9607377]
Hinderliter et al. Page 8













24. Manning G, Rushton L, Donnelly R, Millar-Craig MW. Variability of diurnal changes in
ambulatory blood pressure and nocturnal dipping status in untreated hypertensive and
normotensive subjects. Am J Hypertens. 2000 Sep; 13(9):1035–1038. [PubMed: 10981556]
25. Chaves H, Campello de Souza FM, Krieger EM. The reproducibility of dipping status: beyond the
cutoff points. Blood Press Monit. 2005 Aug; 10(4):201–205. [PubMed: 16077266]
26. Ben-Dov IZ, Ben-Arieh L, Mekler J, Bursztyn M. Blood pressure dipping is reproducible in
clinical practice. Blood Press Monit. 2005 Apr; 10(2):79–84. [PubMed: 15812255]
27. Thijs L, Amery A, Clement D, Cox J, de Cort P, Fagard R, et al. Ambulatory blood pressure
monitoring in elderly patients with isolated systolic hypertension. J Hypertens. 1992 Jul; 10(7):
693–699. [PubMed: 1321198]
28. Edinger JD, Wyatt JK, Olsen MK, Stechuchak KM, Carney CE, Chiang A, et al. Reliability and
validity of the Duke Structured Interview for Sleep Disorders for insomnia screening. Sleep. 2009;
32:0810.
29. Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify
patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999 Oct 5; 131(7):485–491.
[PubMed: 10507956]
30. Sherwood A, Routledge FS, Wohlgemuth WK, Hinderliter AL, Kuhn CM, Blumenthal JA. Blood
pressure dipping: ethnicity, sleep quality, and sympathetic nervous system activity. Am J
Hypertens. 2011 Sep; 24(9):982–988. [PubMed: 21633397]
31. Goodwin J, Bilous M, Winship S, Finn P, Jones SC. Validation of the Oscar 2 oscillometric 24-h
ambulatory blood pressure monitor according to the British Hypertension Society protocol. Blood
Press Monit. 2007 Apr; 12(2):113–117. [PubMed: 17353655]
32. Jones SC, Bilous M, Winship S, Finn P, Goodwin J. Validation of the OSCAR 2 oscillometric 24-
hour ambulatory blood pressure monitor according to the International Protocol for the validation
of blood pressure measuring devices. Blood Press Monit. 2004 Aug; 9(4):219–223. [PubMed:
15311149]
33. Morgenthaler T, Alessi C, Friedman L, Owens J, Kapur V, Boehlecke B, et al. Practice parameters
for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep.
2007 Apr; 30(4):519–529. [PubMed: 17520797]
34. Wang D, Wong KK, Dungan GC 2nd, Buchanan PR, Yee BJ, Grunstein RR. The validity of wrist
actimetry assessment of sleep with and without sleep apnea. J Clin Sleep Med. 2008 Oct 15; 4(5):
450–455. [PubMed: 18853703]
35. Cuspidi C, Meani S, Valerio C, Sala C, Fusi V, Masaidi M, et al. Reproducibility of dipping/
nondipping pattern in untreated essential hypertensive patients: impact of sex and age. Blood Press
Monit. 2007 Apr; 12(2):101–106. [PubMed: 17353653]
36. Omboni S, Parati G, Palatini P, Vanasia A, Muiesan ML, Cuspidi C, et al. Reproducibility and
clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study Study on
Ambulatory Monitoring of Pressure and Lisinopril Evaluation. J Hypertens. 1998 Jun; 16(6):733–
738. [PubMed: 9663912]
37. McGowan NJ, Gough K, Padfield PL. Nocturnal dipping is reproducible in the long term. Blood
Press Monit. 2009 Oct; 14(5):185–189. [PubMed: 19641455]
38. Matthews KA, Kamarck TW, H Hall M, Strollo PJ, Owens JF, Buysse DJ, et al. Blood pressure
dipping and sleep disturbance in African-American and Caucasian men and women. Am J
Hypertens. 2008 Jul; 21(7):826–831. [PubMed: 18483473]
39. Calvo C, Hermida RC, Ayala DE, Lopez JE, Fernandez JR, Dominguez MJ, et al. The 'ABPM
effect' gradually decreases but does not disappear in successive sessions of ambulatory monitoring.
J Hypertens. 2003 Dec; 21(12):2265–2273. [PubMed: 14654746]
40. Hermida RC, Calvo C, Ayala DE, Fernandez JR, Ruilope LM, Lopez JE. Evaluation of the extent
and duration of the “ABPM effect” in hypertensive patients. J Am Coll Cardiol. 2002 Aug 21;
40(4):710–717. [PubMed: 12204501]
41. Lovibond K, Jowett S, Barton P, Caulfield M, Heneghan C, Hobbs FD, et al. Costeffectiveness of
options for the diagnosis of high blood pressure in primary care: a modelling study. Lancet. 2011
Oct 1; 378(9798):1219–1230. [PubMed: 21868086]
Hinderliter et al. Page 9













42. NICE. [Accessed March 30, 2012] Hypertension: The clinical management of primary
hypertension in adults CG127. Available at: http://www.nice.org.uk/guidance/CG127/Guidance
Hinderliter et al. Page 10














Bland Altman plots for systolic BP dip comparing sessions 1 and 2, 2 and 3, and 1 and 3.
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Bland Altman plots comparing sessions 1 and 2 for systolic BP dip, screening systolic BP,
awake systolic BP, and sleep systolic BP.
BP = blood pressure
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Table 1
Characteristics of the study cohort
Characteristic N (%) or mean±SD
Age (yr) 46±9
Female gender 50 (43%)
Race
  White 63 (55%)
  African-American 42 (37%)
  Other 10 (9%)
Body mass index (kg/m2) 28.0±3.7
Shift workers 8 (7%)
Measures of BP
  Screening BP (mmHg) 140±7/90±5
  24-hr BP (mmHg) 132±10/80±8
  Awake BP (mmHg) 136±11/84±8
  Sleep BP (mmHg) 118±12/69±9
  BP dip (mmHg) 18±7/15±5
  Systolic sleep/awake BP ratio 0.87±0.05
  Diastolic sleep/awake BP ratio 0.82±0.06
Data expressed as n (%) for categorical variables and mean±SD for continuous variables, where mean and SD pertain to the average across sessions
1, 2, and 3 for each subject
BP = blood pressure
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Table 2
Measures of sleep duration and quality and of daytime activity
Characteristic Mean±SD Average absolutevariation (mmHg)
Sleep measures
  Sleep time duration (hr) 7.6±1.0 0.6 (0.3–1.1)
  Sleep efficiency 82±8 5.1 (2.9–8.7)
  Fragmentation index 30.8±11.9 9.4 (7.0–14.1)
Activity measure
  Awake activity (counts/min) 233±82 33 (16–55)
Data express as mean±SD or median (interquartile range)
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Table 3








Screening BP (mmHg) 5.3 (3.3–8.0) 5.7 (5.2, 6.3) 0.56 (0.46, 0.66)
24-hour BP (mmHg) 3.7 (2.4–5.6) 4.0 (3.6, 4.4) 0.87 (0.82, 0.90)
Awake BP (mmHg) 3.8 (2.3–5.4) 4.0 (3.7, 4.4) 0.87 (0.83, 0.90)
Sleep BP (mmHg) 5.2 (3.3–7.6) 5.9 (5.4, 6.5) 0.78 (0.72, 0.84)
BP dip (mmHg) 5.2 (3.1–8.1) 5.6 (5.1, 6.1) 0.53 (0.42, 0.63)
Sleep/awake ratio 0.036 (0.025–0.053) 0.039 (0.036, 0.043) 0.55 (0.44, 0.64)
Data expressed as median (interquartile range) for average absolute variation, and value (95% confidence interval) for reproducibility coefficient
and intraclass correlation
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Table 4
Effects of sleep duration and quality and of daytime activity on systolic blood pressure dip
Parameter Estimate S.E. t P
Sleep duration
  Intercept 26.586 5.098
  Mean sleep time duration −0.505 0.735 −0.69 0.493
  Daily sleep time duration −0.618 0.406 −1.52 0.129
Fragmentation index
  Intercept 22.629 1.688
  Mean fragmentation index −0.033 0.062 −0.53 0.595
  Daily fragmentation index −0.115 0.035 −3.26 0.001
Sleep efficiency
  Intercept −4.575 6.129
  Mean sleep efficiency 0.184 0.093 1.99 0.048
  Daily sleep efficiency 0.092 0.055 1.67 0.096
Daytime activity
  Intercept 15.133 1.894
  Mean activity counts/min 0.003 0.012 0.29 0.775
  Daily activity counts/min 0.009 0.009 1.13 0.261
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